Therapeutic Potential for Existing and Novel Forms of Natriuretic Peptides

Heart Failure Clinics

Volumn 2, Issue 3, 2006, Pages 365-373

  Chen, Horng H ^a   Burnett Jr , John C ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; GLYCERYL TRINITRATE; HUMAN SERUM ALBUMIN; HUMAN SERUM ALBUMIN BRAIN NATRIURETIC PEPTIDE; KALIURETIC PEPTIDE; LONG ACTING NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; NESIRITIDE; PEPTIDE HORMONE; PLACEBO; SALBUTAMOL; UNCLASSIFIED DRUG; URODILATIN; VESSEL DILATOR PEPTIDE;

ACUTE HEART FAILURE; ASTHMA; CANCER THERAPY; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; FUNCTIONAL PROTEOMICS; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PANCREAS ADENOCARCINOMA; PHARMACODYNAMICS; PROTEIN FAMILY; PROTEIN FUNCTION; RENAL PROTECTION; REVIEW; TREATMENT INDICATION;

ASTHMA; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDES; NEOPLASMS; VENTRICULAR REMODELING;

EID: 33750796671     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2006.09.003     Document Type: Review

References (55)

1. Chen H.H., and Burnett Jr. J.C. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians 111 (1999) 406
2. Forssmann W., Meyer M., and Forssmann K. The renal urodilatin system: clinical implications. Cardiovas Res 51 (2001) 450
3. Sudoh T., Kangawa K., Minamino N., et al. A new natriuretic peptide in porcine brain. Nature 332 (1988) 78
4. Vesely D.L., San Miguel G.I., Hassan I., et al. Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of total and free T4 and free T3 with reciprocal increase in TSH. J Clin Endocrinol Metab 86 (2001) 5438
5. Wang W., Ou Y., and Shi Y. AlbuBNP, a recombinant B-type natriuretic peptide and human serum albumin fusion hormone, as a long-term therapy of congestive heart failure. Pharm Res 21 (2004) 2105
6. Cataliotti A., Schirger J.A., Martin F.L., et al. Oral human brain natriuretic peptide activates cyclic guanosine 3′,5′-monophosphate and decreases mean arterial pressure. Circulation 112 (2005) 836
7. Schweitz H., Vigne P., Moinier D., et al. A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J Biol Chem 267 (1992) 13928
8. Michel G.H., Murayama N., Sada T., et al. Two N-terminally truncated forms of C-type natriuretic peptide from habu snake venom. Peptides 21 (2000) 609
9. Amininasab M., Elmi M.M., Endlich N., et al. Functional and structural characterization of a novel member of the natriuretic family of peptides from the venom of Pseudocerastes persicus. FEBS Lett 557 (2004) 104
10. Fry B.G., Wickramaratana J.C., Lemme S., et al. Novel natriuretic peptides from the venom of the inland taipan (Oxyuranus microlepidotus): isolation, chemical and biological characterisation. Biochem Biophys Res Commun 327 (2005) 1011
11. Hidaka T., Furuya M., Tani Y., et al. Hemodynamic and neurohumoral effects of carperitide (alpha-human atrial natriuretic peptide) in dogs with low-output heart failure. Nippon Yakurigaku Zasshi 105 (1995) 243
12. Publication Committee for the Intravenous Nesiritide vs Nitroglycerin for Treatment of Decompensated Congestive Heart Failure. A randomized controlled trial. JAMA 287 (2002) 1531
13. Chen H.H., and Burnett J.C. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 32 Suppl 3 (1998) S22
14. Chen H.H., Schirger J.A., Chau W.L., et al. Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure. Circulation 100 (1999) 2443
15. Chen H.H., Grantham J.A., Schirger J.A., et al. Subcutaneous administration of brain natriuretic peptide in experimental heart failure. J Am Coll Cardiol 36 (2000) 1706
16. Belluardo P., Cataliotti A., Bonaiuto L., et al. Lack of activation of the molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy. Am J Physiol Heart Circ Physiol 291 (2006) H1529-H1535
17. Hawkridge A.M., Heublein D.M., Bergen III H.R., et al. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci USA 102 (2005) 17442
18. Chen H.H., Redfield M.M., Nordstrom L.J., et al. Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure. J Card Fail 10 (2004) 115-119
19. Cataliotti A., Boerrigter G., Costello-Boerrigter L.C., et al. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure. Circulation 109 (2004) 1680
20. Yousef Z.R., Redwood S.R., and Marber M.S. Postinfarction left ventricular remodeling: a pathophysiological and therapeutic review. Cardiovasc Drugs Ther 14 (2000) 243
21. Cohn J.N., Ferrari R., and Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35 (2000) 569
22. Brunner-La Rocca H.P., Kaye D.M., Woods R.L., et al. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared to healthy control subjects. J Am Coll Cardiol 37 (2001) 1221
23. Inoue M., Kanda T., Arai M., et al. Impaired expression of brain natriuretic peptide gene in diabetic rats with myocardial infarction. Exp Clin Endocrinol Diabetes 106 (1998) 484
24. Maeda K., Tsutamoto T., Wada A., et al. Insufficient secretion of atrial natriuretic peptide at acute phase of myocardial infarction. J Appl Physiol 89 (2000) 458
25. Hayashi M., Tsutamoto T., Wada A., et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 37 (2001) 1820
26. Asakura M., Jiyoong K., Minamino T., et al. Rationale and design of a large-scale trial using atrial natriuretic peptide (ANP) as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage by ANP (J-WIND-ANP). Circ J 68 (2004) 95
27. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 44 (2004) E1
28. Chen H.H., Cataliotti A., Schirger J.A., et al. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure. Am J Physiol Regul Integr Comp Physiol 288 (2005) R1093
29. Margulies K.B., and Burnett Jr. J.C. Neutral endopeptidase 24.11: a modulator of natriuretic peptides. Semin Nephrol 13 (1993) 71
30. Chen H., Schirger J., Wright R., et al. Intravenous BNP at the time of acute anterior myocardial infarction in humans improves left ventricular remodeling. Circulation 112 Suppl 17 (2005) II
31. Hayashida N., Chihara S., Tayama E., et al. Coronary artery bypass grafting in patients with mild renal insufficiency. Jpn Circ J 65 (2001) 28
32. Anderson R.J., O'Brien M., MaWhinney S., et al. Mild renal failure is associated with adverse outcome after cardiac valve surgery. Am J Kidney Dis 35 (2000) 1127
33. Valsson F., Ricksten S.E., Hedner T., et al. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 22 (1996) 230
34. Wang D.J., Dowling T.C., Meadows D., et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 110 (2004) 1620
35. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487
36. Marcus L.E., Hart D., Packer M., et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 94 (1996) 3184
37. Mills R.M., LeJemtel T.H., Horton D.P., et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 34 (1999) 155
38. Yoshimura M., Yasue H., Morita E., et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84 4 (1991) 1581-1588
39. Riter H.G., Redfield M.M., Burnett J.C., et al. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol 47 (2006) 2334
40. Sezai A., Shiono M., Orime Y., et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg 69 (2000) 732
41. Hebeler F., and Oz M. Effect of perioperative nesiritide administration on postoperative renal function and clinical outcomes in patients undergoing cardiothoracic surgery. Circulation 113 (2006) e807
42. Sakamoto M., Nakao K., Morii N., et al. The lung as a possible target organ for atrial natriuretic polypeptide secreted from the heart. Biochem Biophys Res Commun 135 (1986) 515
43. Panchenko M.V., and Vinogradov A.D. Interaction between the mitochondrial ATP synthetase and ATPase inhibitor protein: active/inactive slow pH-dependent transitions of the inhibitor protein. FEBS Lett 184 (1985) 226
44. Perreault T., and Gutkowska J. Role of atrial natriuretic factor in lung physiology and pathology. Am J Respir Crit Care Med 151 (1995) 226
45. Gutkowska J., and Nemer M. Structure, expression, and function of atrial natriuretic factor in extra-atrial tissues. Endocr Rev 10 (1989) 519
46. Vollmar A.M., and Schulz R. Atrial natriuretic peptide in lymphoid organs of various species. Comp Biochem Physiol A 96 (1990) 459
47. Ohbayashi H., Suito H., and Takagi K. Compared effects of natriuretic peptides on ovalbumin-induced asthmatic model. Eur J Pharmacol 346 (1998) 55
48. Angus R.M., McCallum M.J., Hulks G., et al. Bronchodilator, cardiovascular, and cyclic guanylyl monophosphate response to high-dose infused atrial natriuretic peptide in asthma. Am Rev Respir Dis 147 (1993) 1122
49. Fluge T., Fabel H., Wagner T.O., et al. Bronchodilating effects of natriuretic and vasorelaxant peptides compared to salbutamol in asthmatics. Regul Pept 59 (1995) 357
50. Akerman M.J., Yaegashi M., Khiangte Z., et al. Bronchodilator effect of infused B-type natriuretic peptide in asthma. Chest 130 (2006) 66
51. Fluge T., Forssmann W.G., Kunkel G., et al. Bronchodilation using combined urodilatin-albuterol administration in asthma: a randomized, double-blind, placebo-controlled trial. Eur J Med Res 4 (1999) 411
52. Vesely B.A., McAfee Q., Gower Jr. W.R., et al. Four peptides decrease the number of human pancreatic adenocarcinoma cells. Eur J Clin Invest 33 (2003) 998
53. Vesely D.L., Clark L.C., Garces A.H., et al. Novel therapeutic approach for cancer using four cardiovascular hormones. Eur J Clin Invest 34 (2004) 674
54. Saba S.R., and Vesely D.L. Cardiac natriuretic peptides: hormones with anticancer effects that localize to nucleus, cytoplasm, endothelium, and fibroblasts of human cancers. Histol Histopathol 21 (2006) 775
55. Vesely B.A., Song S., Sanchez-Ramos J., et al. Five cardiac hormones decrease the number of human small-cell lung cancer cells. Eur J Clin Invest 35 (2005) 388